Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: A 7-year follow-up study

Liver International

Volumn 27, Issue 6, 2007, Pages 791-797

  Clemente, Caterina ^a   Elba, Silvana ^a   Buongiorno, Gianpiero ^a   Guerra, Vito ^a   D'Attoma, Benedetta ^a   Orlando, Antonella ^a   Russo, Francesco ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Manganese superoxide dismutase

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHI SQUARE TEST; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PREDICTION; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34447337496     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01485.x     Document Type: Article

References (44)

1. Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12: 680-7.
2. Colombo M, Sangiovanni A. The natural history of hepatocellular carcinoma. Ital J Gastroenterol 1992; 24: 95-9.
3. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398-406.
4. Villa E, Melegari M, Scaglioni PP, Trande P, Cesaro P, Manenti F. Hepatocellular carcinoma: Risk factors other than HBV. Ital J Gastroenterol 1991; 23: 457-60.
5. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.
6. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 2000; 15: 718-24.
7. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nature Rev Cancer 2003; 3: 276-85.
8. Liu R, Buettner GR, Oberley LW. Oxygen free radicals mediate the induction of manganese superoxide dismutase gene expression by TNF-alpha. Free Radic Biol Med 2000; 28: 1197-205.
9. Qadri I, Iwahashi M, Capasso JM, et al. Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: Role of JNK, p38 MAPK and AP-1. Biochem J 2004; 378: 919-28.
10. Cobbs CS, Levi DS, Aldape K, Israel MA. Manganese superoxide dismutase expression in human central nervous system tumors. Cancer Res 1996; 56: 3192-5.
11. Ishikawa M, Yaginuma Y, Hayashi H, Shimizu T, Endo Y, Taniguchi N. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res 1990; 50: 2538-42.
12. Kawamura N, Suzuki K, Ishikawa M, et al. High levels of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell lines. Free Radic Biol Med 1992; 12: 281-6.
13. Schadendorf D, Zuberbier T, Diehl S, Schadendorf C, Czarnetzki BM. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res 1995; 5: 351-3.
14. Chung-Man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 2001; 61: 8578-85.
15. Izutani R, Asano S, Imano M, Kuroda D, Kato M, Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J Gastroenterol 1998; 33: 816-22.
16. Janssen AML, Bosman CB, Sier CFM, et al. Superoxide dismutase in relation to overall survival of colorectal cancer patients. Br J Cancer 1998; 78: 1051-7.
17. Toh Y, Kuninaka S, Oshiro T, Ikeda Y, Nakashima H, Baba H. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int J Oncol 2000; 17: 107-12.
18. Kawaguchi T, Suzuki K, Matsuda Y, et al. Serum-manganese-superoxide dismutase: Normal values and increased levels in patients with acute myocardial infarction and several malignant diseases determined by an enzyme-liked immunosorbent assay using a monoclonal antibody. J Immunol Methods 1990; 127: 249-54.
19. Fortunato G, Castaldo G, Oriani G, et al. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem 2001; 47: 1696-700.
20. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
21. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
22. Loguercio C, Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 2003; 34: 1-10.
23. Cesaratto L, Vascotto C, Calligaris S, Tell G. The importance of redox state in liver damage. Ann Hepatol 2004; 3: 86-92.
24. Chiaromonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-7.
25. Boya P, De La Peña A, Beloqui O, et al. Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. J Hepatol 1999; 31: 808-14.
26. Larrea E, Beloqui O, Muñoz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med 1998; 24: 1235-41.
27. Szabo E, Paska C, Kaposi Novak P, Schaff Z, Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004; 10: 5-11.
28. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 2001; 21: 7721-30.
29. Abdalla MY, Ahmad IM, Spitz DR, Schmidt WN, Britigan BE. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 2005; 76: 489-97.
30. Farinati F, Cardin R, Bortolami M, Guido M, Rugge M. Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol 2006; 12: 2065-9.
31. Sato M, Sasaki M, Hojo H. Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. Arch Biochem Biophys 1995; 316: 738-44.
32. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszeń M. Oxidative stress in the blood of patients with alcohol-related liver cirrhosis. Med Sci Monit 2002; 8: 419-24.
33. Kanbaǧli O, Balkan J, Aykaç-Toker G, Uysal M. Hepatic mitochondrial prooxidant and antioxidant status in ethanol-induced liver injury in rats. Biol Pharm Bull 2002; 25: 1482-4.
34. Koch OR, De Leo ME, Borrello S, Palombini G, Galeotti T. Ethanol treatment up-regulates the expression of mitochondrial manganese superoxide dismutase in rat liver. Biochem Biophys Res Commun 1994; 201: 1356-65.
35. Thome J, Nara K, Foley P, et al. Time course of manganese superoxide dismutase concentrations in serum of alcohol-dependent patients during abstinence. Drug Alcohol Depend 1997; 44: 151-5.
36. Togashi H, Shinzawa H, Wakabayashi H, et al. Activities of free oxygen radical scavenger enzymes in human liver. J Hepatol 1990; 11: 200-5.
37. Bautista AP, Spitzer JJ. Role of Kupffer cells in the ethanol-induced oxidative stress in the liver. Front Biosci 1999; 4: 589-95.
38. Wheeler MD, Kono H, Yin M, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001; 31: 1544-9.
39. Ono M, Kohda H, Kawaguchi T, et al. Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells. Biochem Biophys Res Commun 1992; 182: 1100-7.
40. Aida Y, Maeyama S, Takakuma T, et al. Immunohistochemical expression of manganese superoxide dismutase in hepatocellular carcinoma, using a specific monoclonal antibody. J Gastroenterol 1994; 29: 443-9.
41. Sutton A, Nahon P, Pessayre D, et al. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res 2006; 5: 2844-52.
42. Ito Y, Nakachi K, Imai K, et al. Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. J Epidemiol 2005; 15: S67-73.
43. Das U. A radical approach to cancer. Med Sci Monit 2002; 8: 79-92.
44. Laurent A, Nicco C, Chereau C, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005; 65: 948-56.